Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients
de Las Heras et al.
The finding, in our words
Surveyed oncologists and patients indicated that decentralized trials aim to reduce patient burden, increase enrollment and retention, and improve trial logistics via remote data collection, supporting a patient-centric shift in oncology drug development.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
This review suggests that decentralised clinical trials in oncology can improve patient participation and equity but face significant regulatory, logistical and digital hurdles. It concludes that these trials offer a flexible model dependent on specific clinical contexts rather than a universal replacement for conventional methods.
Gentile et al., Critical reviews in oncology/hematology (paywalled) · source ↗
The study found that although participants preferred patient-centric microsampling devices for home use, the agreement with venous plasma for measuring CRP and cytokines was inconsistent, indicating that further validation is required before these methods replace standard venipuncture.
The study determined that an at-home saliva collection protocol using the passive drool method was feasible for Black women with histories of abuse, with 84% of participants completing at least one full day of adherent sampling. While the decentralised approach yielded usable cortisol data, women with histories of forced sex exposure showed lower protocol adherence scores.
Tsuyuki et al., Interactive journal of medical research (paywalled) · source ↗
In a pilot mixed-methods study of youth with HIV, mailed HemaSpot-HF kits enabled home-based dried blood spot collection that participants found feasible and acceptable, supporting remote viral load monitoring and a self-management model for decentralised care.
Gurung et al., AIDS and behavior (paywalled) · source ↗
In a feasibility randomised controlled trial with 28 adults aged 65 years, 62% successfully self-collected finger-prick capillary blood samples for influenza antibody and vitamin D measurement. While overall study procedures were acceptable, the capillary sampling method requires refinement before wider deployment in decentralised diagnostics for older adults.
Royal et al., Pilot and feasibility studies (paywalled) · source ↗